American Century Companies’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.37M Buy
260,808
+32,388
+14% +$543K ﹤0.01% 1727
2025
Q1
$3.51M Buy
228,420
+11,897
+5% +$183K ﹤0.01% 1750
2024
Q4
$4.77M Buy
216,523
+19,442
+10% +$429K ﹤0.01% 1627
2024
Q3
$3.55M Buy
197,081
+21,903
+13% +$395K ﹤0.01% 1733
2024
Q2
$2.85M Buy
175,178
+20,026
+13% +$325K ﹤0.01% 1753
2024
Q1
$2.19M Sell
155,152
-1,112,455
-88% -$15.7M ﹤0.01% 1850
2023
Q4
$13.2M Sell
1,267,607
-180,358
-12% -$1.88M 0.01% 1033
2023
Q3
$14.8M Sell
1,447,965
-524,576
-27% -$5.35M 0.01% 909
2023
Q2
$14.9M Buy
1,972,541
+129,565
+7% +$976K 0.01% 889
2023
Q1
$16.3M Sell
1,842,976
-89,691
-5% -$794K 0.01% 834
2022
Q4
$17.6M Buy
1,932,667
+28,011
+1% +$255K 0.01% 767
2022
Q3
$15.4M Sell
1,904,656
-158,783
-8% -$1.28M 0.01% 742
2022
Q2
$15.5M Sell
2,063,439
-140,822
-6% -$1.06M 0.01% 763
2022
Q1
$20.7M Buy
2,204,261
+1,694
+0.1% +$15.9K 0.01% 684
2021
Q4
$17.6M Buy
2,202,567
+133,560
+6% +$1.07M 0.01% 731
2021
Q3
$20.2M Sell
2,069,007
-88,519
-4% -$862K 0.01% 679
2021
Q2
$21.4M Buy
2,157,526
+164,113
+8% +$1.62M 0.01% 655
2021
Q1
$23M Buy
1,993,413
+111,100
+6% +$1.28M 0.02% 617
2020
Q4
$18.2M Buy
1,882,313
+32,560
+2% +$314K 0.01% 636
2020
Q3
$16.7M Buy
1,849,753
+628,246
+51% +$5.66M 0.01% 583
2020
Q2
$15.1M Sell
1,221,507
-368,419
-23% -$4.54M 0.01% 582
2020
Q1
$14.3M Sell
1,589,926
-777,174
-33% -$6.98M 0.02% 520
2019
Q4
$23.2M Sell
2,367,100
-794,857
-25% -$7.79M 0.02% 480
2019
Q3
$21.8M Buy
3,161,957
+394,355
+14% +$2.71M 0.02% 471
2019
Q2
$25.5M Buy
2,767,602
+844,992
+44% +$7.8M 0.03% 465
2019
Q1
$30.1M Buy
1,922,610
+265,171
+16% +$4.16M 0.03% 436
2018
Q4
$25.6M Buy
1,657,439
+358,110
+28% +$5.52M 0.03% 444
2018
Q3
$28M Buy
1,299,329
+305,040
+31% +$6.57M 0.03% 456
2018
Q2
$24.2M Sell
994,289
-156,127
-14% -$3.8M 0.02% 482
2018
Q1
$19.7M Buy
1,150,416
+40,375
+4% +$690K 0.02% 512
2017
Q4
$21M Sell
1,110,041
-495,886
-31% -$9.4M 0.02% 506
2017
Q3
$28.3M Sell
1,605,927
-390,468
-20% -$6.87M 0.03% 464
2017
Q2
$66.3M Buy
1,996,395
+204,688
+11% +$6.8M 0.07% 335
2017
Q1
$57.5M Buy
1,791,707
+120,041
+7% +$3.85M 0.06% 350
2016
Q4
$60.6M Sell
1,671,666
-1,223,591
-42% -$44.4M 0.07% 339
2016
Q3
$133M Buy
2,895,257
+331,520
+13% +$15.3M 0.15% 200
2016
Q2
$129M Sell
2,563,737
-33,076
-1% -$1.66M 0.15% 196
2016
Q1
$139M Buy
2,596,813
+41,284
+2% +$2.21M 0.16% 182
2015
Q4
$168M Buy
2,555,529
+819,677
+47% +$53.8M 0.2% 143
2015
Q3
$98M Buy
1,735,852
+102,592
+6% +$5.79M 0.12% 225
2015
Q2
$96.5M Sell
1,633,260
-1,333,813
-45% -$78.8M 0.11% 252
2015
Q1
$185M Sell
2,967,073
-1,590,059
-35% -$99.1M 0.21% 142
2014
Q4
$262M Buy
4,557,132
+172,265
+4% +$9.91M 0.3% 90
2014
Q3
$236M Buy
4,384,867
+134,217
+3% +$7.21M 0.28% 104
2014
Q2
$223M Buy
4,250,650
+3,688,500
+656% +$193M 0.25% 105
2014
Q1
$29.7M Sell
562,150
-445,480
-44% -$23.5M 0.04% 466
2013
Q4
$40.4M Buy
1,007,630
+708,380
+237% +$28.4M 0.05% 396
2013
Q3
$11.3M Buy
299,250
+650
+0.2% +$24.6K 0.01% 674
2013
Q2
$11.7M Buy
+298,600
New +$11.7M 0.02% 632